Seguir
Christa E. Müller
Título
Citado por
Citado por
Año
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
14032011
Recent developments in adenosine receptor ligands and their potential as novel drugs
CE Müller, KA Jacobson
Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011
4442011
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ...
Nature 509 (7498), 115-118, 2014
3812014
Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors
T Gnad, S Scheibler, I von Kügelgen, C Scheele, A Kilić, A Glöde, ...
Nature 516 (7531), 395-399, 2014
3262014
Agonist-bound structure of the human P2Y12 receptor
J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ...
Nature 509 (7498), 119-122, 2014
3082014
Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids
P Carriba, O Ortiz, K Patkar, Z Justinova, J Stroik, A Themann, C Müller, ...
Neuropsychopharmacology 32 (11), 2249-2259, 2007
2942007
Anthraquinones as pharmacological tools and drugs
EM Malik, CE Müller
Medicinal research reviews 36 (4), 705-748, 2016
2932016
The experimental power of FR900359 to study Gq-regulated biological processes
R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ...
Nature communications 6 (1), 1-17, 2015
2712015
CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice
X Sun, Y Wu, W Gao, K Enjyoji, E Csizmadia, CE Müller, T Murakami, ...
Gastroenterology 139 (3), 1030-1040, 2010
2672010
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress
MP Kaster, NJ Machado, HB Silva, A Nunes, AP Ardais, M Santana, ...
Proceedings of the National Academy of Sciences 112 (25), 7833-7838, 2015
2472015
Medicinal chemistry of adenosine, P2Y and P2X receptors
KA Jacobson, CE Müller
Neuropharmacology 104, 31-49, 2016
2392016
CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury
D Köhler, T Eckle, M Faigle, A Grenz, M Mittelbronn, S Laucher, ML Hart, ...
Circulation 116 (16), 1784-1794, 2007
2302007
Prodrug approaches for enhancing the bioavailability of drugs with low solubility
CE Mueller
Chemistry & Biodiversity 6 (11), 2071-2083, 2009
2232009
Lignans Isolated from Valerian:  Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors
B Schumacher, S Scholle, J Hölzl, N Khudeir, S Hess, CE Müller
Journal of Natural Products 65 (10), 1479-1485, 2002
2232002
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British Journal of Pharmacology 178, S27-S156, 2021
2162021
Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP)
A Pick, H Müller, R Mayer, B Haenisch, IK Pajeva, M Weigt, H Bönisch, ...
Bioorganic & medicinal chemistry 19 (6), 2090-2102, 2011
2122011
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration
M Karcz-Kubicha, K Antoniou, A Terasmaa, D Quarta, M Solinas, ...
Neuropsychopharmacology 28 (7), 1281-1291, 2003
2092003
Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A2A-selective adenosine receptor antagonists
R Sauer, J Maurinsh, U Reith, F Fülle, KN Klotz, CE Müller
Journal of medicinal chemistry 43 (3), 440-448, 2000
2082000
Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
CE Müller, J Iqbal, Y Baqi, H Zimmermann, A Röllich, H Stephan
Bioorganic & medicinal chemistry letters 16 (23), 5943-5947, 2006
2002006
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
MT Armentero, A Pinna, S Ferré, JL Lanciego, CE Müller, R Franco
Pharmacology & therapeutics 132 (3), 280-299, 2011
1962011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20